Be quiet and you'll keep young: Does mTOR underlie p53 action in protecting against senescence by favoring quiescence?

Aging

Volumn 3, Issue 1, 2011, Pages 3-4

  Dulic, Vjekoslav ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TARGET OF RAPAMYCIN KINASE;

ANIMAL; CELL AGING; CELL CYCLE; HUMAN; METABOLISM; NEOPLASM; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL CYCLE; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958248002     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100257     Document Type: Note

References (16)

1. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.
2. Sage J et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 2000; 14:3037-3050.
3. Herbig U et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell. 2004; 14:501-513.
4. Vousden KH and Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009; 9:691-700.
5. Sherr CJ and Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999; 13:1501- 1512.
6. Dulic V et al. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol. 2000; 20:6741-6754.
7. Demidenko ZN et al. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A. 2010.;107:9660- 9664.
8. Blagosklonny MV. Cell senescence and hypermitogenic arrest. EMBO Rep, 2003; 4:358-362.
9. Demidenko ZN and Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle. 2008; 7:3355-33561.
10. Korotchkina LG et al. Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A. Cell Cycle. 2009; 8:3777-3781.
11. Demidenko ZN and Blagosklonny MV. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence. Cell Cycle. 2009; 8:1901-1904.
12. Korotchkina LG et al. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging. 2010; 2:344-352.
13. Maki CG. Decision-making by p53 and mTOR. Aging. 2010; 2:324-326.
14. Leontieva OV and Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging, 2010; 2:924-935.
15. Toker A. mTOR and Akt signaling in cancer: SGK cycles in. Mol Cell. 2008; 31:6-8.
16. Narita M et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 2003; 113:703-716.